110 related articles for article (PubMed ID: 11907156)
1. Beta(1)-selective agonist (-)-1-(3,4-dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(-)-RO363] differentially interacts with key amino acids responsible for beta(1)-selective binding in resting and active states.
Sugimoto Y; Fujisawa R; Tanimura R; Lattion AL; Cotecchia S; Tsujimoto G; Nagao T; Kurose H
J Pharmacol Exp Ther; 2002 Apr; 301(1):51-8. PubMed ID: 11907156
[TBL] [Abstract][Full Text] [Related]
2. Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
Isogaya M; Sugimoto Y; Tanimura R; Tanaka R; Kikkawa H; Nagao T; Kurose H
Mol Pharmacol; 1999 Nov; 56(5):875-85. PubMed ID: 10531390
[TBL] [Abstract][Full Text] [Related]
3. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
4. Murine ventricular L-type Ca(2+) current is enhanced by zinterol via beta(1)-adrenoceptors, and is reduced in TG4 mice overexpressing the human beta(2)-adrenoceptor.
Heubach JF; Graf EM; Molenaar P; Jäger A; Schröder F; Herzig S; Harding SE; Ravens U
Br J Pharmacol; 2001 May; 133(1):73-82. PubMed ID: 11325796
[TBL] [Abstract][Full Text] [Related]
5. The affinity and efficacy of the selective beta 1-adrenoceptor stimulant RO363 at beta 1- and beta 2-adrenoceptor sites.
McPherson GA; Malta E; Molenaar P; Raper C
Br J Pharmacol; 1984 Aug; 82(4):897-904. PubMed ID: 6148117
[TBL] [Abstract][Full Text] [Related]
6. The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005.
Kikkawa H; Isogaya M; Nagao T; Kurose H
Mol Pharmacol; 1998 Jan; 53(1):128-34. PubMed ID: 9443940
[TBL] [Abstract][Full Text] [Related]
7. The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation.
Hwa J; Perez DM
J Biol Chem; 1996 Mar; 271(11):6322-7. PubMed ID: 8626427
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of RO363, a beta1-adrenoceptor selective agonist.
Iakovidis D; Malta E; McPherson GA; Raper C
Br J Pharmacol; 1980 Apr; 68(4):677-85. PubMed ID: 6103722
[TBL] [Abstract][Full Text] [Related]
9. Agonist interactions with chimeric and mutant beta1- and beta3-adrenergic receptors: involvement of the seventh transmembrane region in conferring subtype specificity.
Granneman JG; Lahners KN; Zhai Y
Mol Pharmacol; 1998 May; 53(5):856-61. PubMed ID: 9584211
[TBL] [Abstract][Full Text] [Related]
10. Constitutively active mutants of the beta1-adrenergic receptor.
Lattion A; Abuin L; Nenniger-Tosato M; Cotecchia S
FEBS Lett; 1999 Sep; 457(3):302-6. PubMed ID: 10471797
[TBL] [Abstract][Full Text] [Related]
11. Domains of beta1 and beta2 adrenergic receptors to bind subtype selective agonists.
Kurose H; Isogaya M; Kikkawa H; Nagao T
Life Sci; 1998; 62(17-18):1513-7. PubMed ID: 9585128
[TBL] [Abstract][Full Text] [Related]
12. Agonist binding and activation of the rat beta(1)-adrenergic receptor: role of Trp(134(3.28)), Ser(190(4.57)) and Tyr(356(7.43)).
Rezmann-Vitti LA; Louis SN; Nero TL; Jackman GP; Iakovidis D; Machida CA; Louis WJ
Biochem Pharmacol; 2004 Aug; 68(4):675-88. PubMed ID: 15276075
[TBL] [Abstract][Full Text] [Related]
13. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation.
Miura S; Kawanaka K; Kai Y; Tamura M; Goto M; Shiuchi T; Minokoshi Y; Ezaki O
Endocrinology; 2007 Jul; 148(7):3441-8. PubMed ID: 17446185
[TBL] [Abstract][Full Text] [Related]
14. Beta2- and beta3-adrenoceptors activate glucose uptake in chick astrocytes by distinct mechanisms: a mechanism for memory enhancement?
Hutchinson DS; Summers RJ; Gibbs ME
J Neurochem; 2007 Nov; 103(3):997-1008. PubMed ID: 17680985
[TBL] [Abstract][Full Text] [Related]
15. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional roles of small group-conserved amino acids present on helix-H7 in the β(2)-adrenergic receptor.
Arakawa M; Chakraborty R; Upadhyaya J; Eilers M; Reeves PJ; Smith SO; Chelikani P
Biochim Biophys Acta; 2011 Apr; 1808(4):1170-8. PubMed ID: 21262196
[TBL] [Abstract][Full Text] [Related]
17. Mutation of important amino acid residue of Asp104Lys in human beta(1)-adrenergic receptor triggers functional and constitutive inactivation.
Hossain M; Ahmed M; Bhuiyan MA; Ishiguro M; Nakamura T; Ozaki M; Nagatomo T
Biol Pharm Bull; 2008 Aug; 31(8):1517-22. PubMed ID: 18670082
[TBL] [Abstract][Full Text] [Related]
18. A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated.
Pei G; Samama P; Lohse M; Wang M; Codina J; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2699-702. PubMed ID: 7908440
[TBL] [Abstract][Full Text] [Related]
19. Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by beta1- and beta2-adrenergic receptor activation in human myocardium.
Carceles MD; Fuentes T; Aroca V; Lopez J; Hernández J
Clin Ther; 2007 Aug; 29(8):1718-24. PubMed ID: 17919552
[TBL] [Abstract][Full Text] [Related]
20. Mutagenesis of important amino acid reveals unconventional homologous internalization of beta(1)-adrenergic receptor.
Hossain M; Rashid M; Bhuiyan MA; Nakamura T; Ozaki M; Nagatomo T
Life Sci; 2009 Aug; 85(7-8):339-44. PubMed ID: 19580817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
